✦ LIBER ✦

Phase I study of a neutralizing monoclonal anti-CTLA4 antibody (MDX-010) in patients with relapse of malignancy after allogeneic hematopoietic stem cell transplantation

✍ Scribed by A. Bashey; B. Medina; R.-K. Zhong; J.-H. Zhou; E. Carrier; J. Castro; P. Holman; T.A. Lane; C. Sun; I. Lowy; S. Corringham; R. Soiffer; J. Mason; E.D. Ball

Book ID: 116277971
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 59 KB
Volume: 11
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2004.12.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I rapid dose-escalation study of A

Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial

✍ Emmanuel S. Antonarakis; Michael A. Carducci; Mario A. Eisenberger; Samuel R. De 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 316 KB

Immunotherapy with FBTA05 (Bi20), a trif

Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial

✍ Raymund Buhmann, Stanglmaier Michael, Hess Juergen… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 328 KB

Identification of an AUC of 7603 Umol∗Mi

Identification of an AUC of 7603 Umol∗Min/Hr Per Day X 4 Days as the Maximum Tolerated Dose (MTD) of IV Continuous Infusion (CI) Busulfan (BU) with Fixed Dose Fludarabine (FLU) in A Pharmacokinetically-Based Dose Phase I Study in Patients (PTS) with Hematologic Malignancies Undergoing Allogeneic Stem Cell Transplantation

✍ W.A. Wood; C.M. Walko; K.V. Rao; J. Whitley; D.T. Moore; D.A. Gabriel; J.S. Sero 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB